Karyn Koladicz, MD

Title: Executive Medical Director for Medical Affairs, Neurology PTC Therapeutics

Bio: Karyn is a Pediatric Neurologist specializing in Genetic inborn errors of the metabolism and metabolic disorders. She received her medical degree at Pontifícia universidade católica do Paraná in Brazil. Karyn joined PTC Therapeutics in 2015 and is currently the Executive Medical Director for Medical Affairs, Neurology.

2023 FUTURES: Preserving Muscle Sessions

A brief primer on the muscle preservation and anti-inflammatory treatment approach to Duchenne, and updates from relevant companies in the space. These presentations will be followed by a moderated Q&A opportunity.

Abby Bronson

Vice President, Patient Advocacy & External Innovation

Edgewise Therapeutics

See more from same speaker

Robert Halter, PharmD

Field Medical Director, South/Southwest Santhera Pharmaceuticals

See more from same speaker

Karyn Koladicz, MD

Executive Medical Director for Medical Affairs, Neurology PTC Therapeutics

See more from same speaker

Linda Marbán , PhD

President, CEO and Director Capricor Therapeutics

See more from same speaker

Video
Share this:
Beginning the Journey - diagnosed 0-3 yearsGrowth and Transformation - diagnosed 3-6 yearsSpreading Wisdom - diagnosed 6+ years

2024 FUTURES – Therapies to Preserve and Protect Muscle

Presentations covering therapies aiming to preserve and protect muscle in Duchenne, including anti-inflammatory agents, muscle stabilizers, and other mechanisms with relevant updates from companies in the space.

 

Karyn Koladicz, MD

Executive Medical Director for Medical Affairs, Neurology PTC Therapeutics

See more from same speaker

Lianna Orlando, PhD

Senior Director of Research

CureDuchenne

See more from same speaker

Abby Bronson

Vice President, Patient Advocacy & External Innovation

Edgewise Therapeutics

See more from same speaker

Stanley Iyadurai, MD, PhD

Sr VP Medical Affairs and Drug Discovery

Catalyst

See more from same speaker

Scott Baver, PhD

Head of Medical Affairs

ITF Therapeutics

See more from same speaker

Mark Awadalla

Vice President of Clinical Operations

Capricor

See more from same speaker

Video
Share this:
Beginning the Journey - diagnosed 0-3 yearsGrowth and Transformation - diagnosed 3-6 yearsSpreading Wisdom - diagnosed 6+ years